期刊
JOURNAL OF MOLECULAR BIOLOGY
卷 387, 期 5, 页码 1061-1066出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jmb.2009.02.033
关键词
antibody; glycosylation; oligomannose; antibody engineering; kifunensine
资金
- Cancer Research UK
- UK Medical Research Council
- European Commission as SPINE2 Complexes [FP6-RTD-031220]
- Wellcome Trust
- MRC [G0700232, G0500365, G9900061, G0500367] Funding Source: UKRI
- Medical Research Council [G0500365, G0700232, G9900061, G0500367] Funding Source: researchfish
Antibodies contain a conserved glycosylation site that has emerged as a target for the modulation of antibody effector functions. The crystal structure of a biosynthetic intermediate of human IgG1, bearing immature oligomannose-type glycans and reported to display increased antibody-dependent cellular cytotoxicity, demonstrates that glycan engineering can bias the Fc to an open conformation primed for receptor binding. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据